SPOTLIGHT -
From the Pages of Psychiatric Times: January 2024
The experts weighed in on a wide variety of psychiatric issues for the January 2024 issue of Psychiatric Times.
The Week in Review: January 22-26
From noninvasive brain stimulation for substance use disorders to updates from APSARD 2024, here are highlights from the week in Psychiatric Times.
Clinician Wellness Research Roundup: January 26, 2024
What is new in research on clinician wellness?
Drug Candidate for Schizophrenia, Alzheimer Disease Approved to Initiate Phase 2 Trial in Q2 2024
The candidate also aims to address neurodevelopmental and neurodegenerative disorders such as Parkinson disease and Rett syndrome.
Addressing Suicide and Other Mental Health Crises With 988
US suicide rates reached an all-time high in 2022. Here’s how effective implementation of 988 can help address the problem.
The Week in Review: January 15-19
From clinician wellness to THC use in adolescents, here are highlights from the week in Psychiatric Times.
Phase 3 Trial Data Supports Efficacy of Novel Treatment for ADHD in Adults
The results were shared in a poster presentation at the 2024 APSARD Annual Meeting.
COVID-19 and Mental Health Research Roundup: January 19, 2024
What is new in research on COVID-19 and mental health?
Clinician Wellness in Psychiatric Times
Take a look back at our recent coverage relating to our January content theme.
In Conversation With a Sigourney Award Winner: The Intersection of History, Humanities, and Psychoanalytic Thought
“Freudian thought has massively influenced not only modern understandings of mind and therapeutic treatment, but also modernism and many distinct visions of politics.”
The Week in Review: January 8-12
From substance use disorders in physicians to new research on the efficacy of MDMA-assisted therapy for PTSD, here are highlights from the week in Psychiatric Times.
Sleep Research Roundup: January 12, 2024
What is new in research on sleep?
The Week in Review: January 1-5
From a groundbreaking new launch for PTSD in the United States to connections between antidepressant treatment and metabolic syndrome, here are highlights from the week in Psychiatric Times.
PTSD Research Roundup: January 5, 2024
What is new in research on posttraumatic stress disorder?
Presenting Our January Theme: Clinician Wellness
Write to us now to be part of our series focused on clinician wellness this month.
Phase 3 Topline Results Support Sustained Efficacy, Tolerability of Treatment for Schizophrenia, Bipolar I Disorder
The data assess the extended efficacy of the treatment for up to 4 years.
First FDA-Approved Self-Neuromodulation Device for PTSD Officially Launches in the US
The device is now available at 2 US clinics, with training and installation currently underway at several other locations.
Prescription Digital Therapeutic for Schizophrenia Receives FDA Breakthrough Device Designation
The device is currently under clinical trial investigation as an adjunct treatment to standard of care therapy for experiential negative symptoms of schizophrenia.
Psychiatry in the News: December 2023
Here are some updates from the world of psychiatry throughout the month of December.
Seasonal Affective Disorder Research Roundup: December 29, 2023
What is new in research on seasonal affective disorder?
From the Pages of Psychiatric Times: December 2023
The experts weighed in on a wide variety of psychiatric issues for the December 2023 issue of Psychiatric Times.
The Year in Cover Stories 2023
Here are highlights from some of the year’s top features in Psychiatric Times from throughout 2023.
Continuing Medical Education 2023
Reviewing a year of CMEs in Psychiatric Times®
The Week in Review: December 18-22
From new guidelines for the utilization of artificial intelligence in health care to the efficacy of fish oil as a replacement for antidepressants, here are highlights from the week in Psychiatric Times.
Schizophrenia Research Roundup: December 22, 2023
What is new in research on schizophrenia?
Insights and Highlights From the Annual Psychiatric Times World CME Conference
Did you miss the 2023 Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.
The Week in Review: December 11-15
From a new look at the famous STAR*D study to updates from the National Academy of Sciences Conference on Adult ADHD, here are highlights from the week in Psychiatric Times.
ADHD Research Roundup: December 15, 2023
What is new in research on ADHD?
Positive Topline Results Announced for Phase 2b Clinical Trial of GAD Treatment
“This is the first study to assess the standalone drug effects of MM-120 in the absence of any psychotherapeutic intervention.”
The Week in Review: December 4-8
From adjunctive cariprazine for the treatment of major depressive disorder to a new app for prescribing antidepressants and antipsychotics, here are highlights from the week in Psychiatric Times.